Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology
- PMID: 24713617
- DOI: 10.1177/0269881114525674
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology
Abstract
This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees.
Keywords: Anticonvulsants; antidepressants; antipsychotics; anxiety disorders; anxiolytics; benzodiazepines; cognitive behaviour therapy; evidence-based guidelines; generalised anxiety disorder; obsessive-compulsive disorder; panic disorder; post-traumatic stress disorder; pregabalin; selective serotonin reuptake inhibitor; separation anxiety disorder; serotonin-noradrenaline reuptake inhibitor; social anxiety disorder; specific phobia; treatment.
Similar articles
-
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.J Psychopharmacol. 2005 Nov;19(6):567-96. doi: 10.1177/0269881105059253. J Psychopharmacol. 2005. PMID: 16272179
-
The pharmacologic treatment of anxiety disorders: a review of progress.J Clin Psychiatry. 2010 Jul;71(7):839-54. doi: 10.4088/JCP.10r06218blu. J Clin Psychiatry. 2010. PMID: 20667290 Review.
-
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.World J Biol Psychiatry. 2008;9(4):248-312. doi: 10.1080/15622970802465807. World J Biol Psychiatry. 2008. PMID: 18949648
-
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. doi: 10.3109/13651501.2012.667114. Epub 2012 Apr 30. Int J Psychiatry Clin Pract. 2012. PMID: 22540422
-
Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.J Affect Disord. 2010 Jun;123(1-3):9-16. doi: 10.1016/j.jad.2009.06.021. Epub 2009 Jul 17. J Affect Disord. 2010. PMID: 19616306
Cited by
-
Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders.Neuropsychiatr Dis Treat. 2016 Oct 17;12:2659-2676. doi: 10.2147/NDT.S118058. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27799774 Free PMC article.
-
Anxiety and Hypertension: Is There a Link? A Literature Review of the Comorbidity Relationship Between Anxiety and Hypertension.Curr Hypertens Rep. 2019 Jul 18;21(9):66. doi: 10.1007/s11906-019-0972-5. Curr Hypertens Rep. 2019. PMID: 31321565 Review.
-
The effect of SSRIs on fear learning: a systematic review and meta-analysis.Psychopharmacology (Berl). 2023 Nov;240(11):2335-2359. doi: 10.1007/s00213-023-06333-7. Epub 2023 Feb 27. Psychopharmacology (Berl). 2023. PMID: 36847831 Free PMC article. Review.
-
Effects of exercise on symptoms of anxiety, cognitive ability and sick leave in patients with anxiety disorders in primary care: study protocol for PHYSBI, a randomized controlled trial.BMC Psychiatry. 2019 Jun 10;19(1):172. doi: 10.1186/s12888-019-2169-5. BMC Psychiatry. 2019. PMID: 31182054 Free PMC article.
-
Using caffeine on the patients as therapeutic option against treatment-resistant obsessive-compulsive disorder.J Family Med Prim Care. 2019 May;8(5):1741-1747. doi: 10.4103/jfmpc.jfmpc_93_19. J Family Med Prim Care. 2019. PMID: 31198747 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical